-
disease (MASLD),
previously known as non-alcoholic
fatty liver disease (
NAFLD), is a type of
chronic liver disease. This
condition is
diagnosed when there...
-
steatotic liver disease (MASLD,
formerly "non-alcoholic
fatty liver disease" (
NAFLD)) and alcohol-****ociated
liver disease (ALD), with the
category "metabolic...
-
steatotic liver disease,
previously called non-alcoholic
fatty liver disease or
NAFLD),
heroin abuse,
chronic hepatitis B, and
chronic hepatitis C.
Chronic heavy...
-
disease (
NAFLD), alcohol-related
liver disease (ALD), and
viral hepatitis, are
significant public health concerns worldwide. In the
United States,
NAFLD is...
- X receptor, a
therapeutic target for
nonalcoholic fatty liver disease (
NAFLD).
During the COVID-19 pandemic,
ivermectin was
researched for
possible utility...
-
insulin resistance, hypertriglyceridemia, non-alcoholic
fatty liver disease (
NAFLD) and
metabolic syndrome.
Lipodystrophy can be
divided into the following...
- drug for the
treatment of type 2
diabetes mellitus, dyslipidemia, NASH and
NAFLD It is
approved for use in
India by the Drug
Controller General of India...
-
ranges in
severity and
reversibility from non-alcoholic
fatty liver disease (
NAFLD) to non-alcoholic
steatohepatitis (NASH) to
cirrhosis to
liver cancer, similar...
- (nonalcoholic steatohepatitis,
NAFLD) are
relatively common and can
slowly progress to end-stage
liver disease.
NAFLD sensitizes the
liver to
injury and...
- resistance.
Polycystic ovary syndrome and non-alcoholic
fatty liver disease (
NAFLD) are ****ociated with
insulin resistance.
Hepatitis C also
makes people three...
